dupixent and tirzepatide Dispensations Increased Rapidly After Approval Dupixent Side Effects, Risks and

Avoid fatty and greasy foods

For weight management, the Food and Drug Administration (FDA) has approved two medications: Semaglutide (Wegovy) Tirzepatide (Zepbound) These drugs contain the same active ingredients as diabetes medications such as Ozempic and Mounjaro, but Wegovy and Zepbound are specifically approved for chronic weight management

A new side effect for dysesthesia (altered skin sensation) was noted but was mild and rarely led to discontinuation

clusterProfiler: an R Package for comparing Biological themes among Gene clusters

Zepbound works best when combined with nutritious eating, regular physical activity, adequate sleep, and ongoing medical guidance